Biotech · Private company · San Carlos, CA, US
Envivo Bio Inc
Track this companyFree. Adds Envivo Bio Inc to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CapScanPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- CapScan collection capsulePhase 1 · Small Intestinal Bacterial OvergrowthClinicalTrials.gov · fetched Nov 12, 2026
- CapScan intestinal sampling deviceHealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScanPHASE1 · NOT_YET_RECRUITING · started Dec 1, 2025ClinicalTrials.gov NCT07054593 · fetched Nov 12, 2026
- Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®PHASE1 · RECRUITING · started Feb 15, 2024ClinicalTrials.gov NCT06298409 · fetched Nov 12, 2026
- Evaluation of the CapScan Device to Measure the Metabolism of SulfasalazineNA · COMPLETED · started Sep 1, 2022ClinicalTrials.gov NCT05749068 · fetched Nov 12, 2026
NIH awards2
- Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoringFiscal year 2025 · $594.5KNIH RePORTER 5R33CA260665-04 · fetched Nov 12, 2026
- Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoringFiscal year 2024 · $569.7KNIH RePORTER 5R33CA260665-03 · fetched Nov 12, 2026